Amneal Pharmaceuticals, Inc. - COM STK CL A (AMRX)

Q2 2020 13F Holders as of 6/30/2020

Type / Class
Equity / COM STK CL A
Number of holders
131
Total Shares
102M
Shares change
+3.24M
Total reported value, excl. options
$484M
Value change
+$16.6M
Put/Call ratio
0.52
Number of buys
62
Number of sells
-68
Price
$4.76
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.